about
Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replicationImmune signaling by RIG-I-like receptorsInhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virusRegulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infectionAlpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replicationRegulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-IInterferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shockInnate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNATargeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR PathwayRegulation of Retinoic Acid Inducible Gene-I (RIG-I) Activation by the Histone Deacetylase 6Regulation of hepatic innate immunity by hepatitis C virusIL-1β signaling promotes CNS-intrinsic immune control of West Nile virus infectionRegulation of PKR and IRF-1 during hepatitis C virus RNA replication.West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling.PKR and RNase L Contribute to Protection against Lethal West Nile Virus Infection by Controlling Early Viral Spread in the Periphery and Replication in NeuronsResistance to Alpha/Beta Interferon Is a Determinant of West Nile Virus Replication Fitness and VirulenceRegulation of CXCL-8 (Interleukin-8) Induction by Double-Stranded RNA Signaling Pathways during Hepatitis C Virus InfectionHepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteinsCell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent MechanismsDistinct RIG-I and MDA5 Signaling by RNA Viruses in Innate ImmunityEstablishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1Interferon Regulatory Factor IRF-7 Induces the Antiviral Alpha Interferon Response and Protects against Lethal West Nile Virus InfectionToll-Like Receptor 3 Has a Protective Role against West Nile Virus InfectionInnate immune evasion by hepatitis C virus and West Nile virusApolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptorMechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.IPS-1 Is Essential for the Control of West Nile Virus Infection and ImmunityNonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responsesStructural basis of RNA recognition and activation by innate immune receptor RIG-IIdentifying protective host gene expression signatures within the spleen during West Nile virus infection in the collaborative cross modelRIG-I in RNA virus recognitionViruses and interferon: a fight for supremacyInterferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection2'-O methylation of the viral mRNA cap evades host restriction by IFIT family membersProteomic analysis of mitochondrial-associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and organelle traffickingInflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitisConvergent evolution of escape from hepaciviral antagonism in primatesImmune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIFEvasion of intracellular host defence by hepatitis C virus
P50
Q24302046-A3820EBE-7559-43C5-A32B-90D057884F2AQ24304438-3B022995-5C44-4442-B395-1913F1787F21Q24311228-905D32AF-ADFC-4C5B-9B2F-152C6944A0D5Q24338327-AF214245-49F2-4670-AAF3-135CA411FF72Q24546318-A09C8C75-52AD-4754-B63F-5F73603F2EA6Q24551046-37DEC573-EA3C-41E9-9882-7106CFF90258Q24556673-BD749456-6D8D-42F5-ACA3-42BC42CF8DA6Q24598171-E1139A08-E02E-4D89-800D-16618A56B256Q24634416-DB826E7B-E9BE-464E-A680-EDD4B4C9DABFQ26700090-D04CE9F2-C11F-4ECF-BF7F-D4660AC945E1Q26700093-AA30BB05-D16A-4CC5-8A95-12DC3F448C05Q26824743-9745D143-61A4-4C96-A634-1D5EC4169018Q27340022-D1DF55CC-18FA-4116-871B-C22127F89454Q27472373-3FBB0304-9813-4638-850B-D763C8A207D5Q27473048-B769AC5C-DBBD-48F2-9C2D-33AFA5702A2BQ27473291-76F54D9C-0AA1-4822-99D6-3BBD361CC72AQ27477539-1D76974E-AAA8-474F-945D-605BF4FAEC7DQ27478028-C00B4ECF-2497-46C2-A504-D262BAB6F0EBQ27478188-8B4345E9-D645-4C25-B722-F21D8F3B1864Q27480936-52E72F12-A3B7-47FA-A727-C142FC122295Q27485306-95EFDA1E-DEEA-427A-BF64-F255A73A9734Q27485316-399549E8-422F-4665-B71A-38156A2379C3Q27486785-40E58884-E223-413C-8853-7B9C06DCF049Q27487124-6265C488-A6FC-4E2F-B0BF-7FE3BED4D4C2Q27489865-ACCAF9B1-BFC1-4239-A345-22D1DB289347Q27490234-95E270F8-060D-4F7E-9A24-262D09656652Q27490650-E6A288C3-35A5-4F1C-8C1F-C7EAEACB2426Q27490889-7CEF7030-892C-4830-B680-D3BE10E6D148Q27649758-4F22A5BB-195A-4240-9678-E5706E403CBAQ27674465-BE484DF6-5F42-4108-B921-4B47993EAB1AQ27928022-D69C5FAC-B40E-48D5-BA8D-4586E1871005Q28081618-97A3285E-7BFF-4401-999C-2E50A19BCDAEQ28220397-37FA203D-40DA-4900-8852-94E311934BFAQ28508364-8FE5A6D8-0642-434B-86C2-2CAF88F87206Q28513232-BF7ED39C-5C6B-4BFE-9B13-1F7678C05188Q28543776-A6C4C39C-A512-4B2E-98CB-F737E1B855C6Q28593473-2860703F-DCBE-42A0-AFAE-1669BB71F282Q28731324-A6DA41B2-A3DE-45EB-972C-D99CA9DE250DQ29547901-C13676EB-8E3E-49CA-A8D7-93718F61F74DQ29618976-0215664C-4C7E-4F26-88CF-C7AFA1337044
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael Gale
@ast
Michael Gale
@en
Michael Gale
@es
Michael Gale
@nl
Michael Gale
@sl
type
label
Michael Gale
@ast
Michael Gale
@en
Michael Gale
@es
Michael Gale
@nl
Michael Gale
@sl
altLabel
Mike
@en
prefLabel
Michael Gale
@ast
Michael Gale
@en
Michael Gale
@es
Michael Gale
@nl
Michael Gale
@sl
P106
P1153
55382766000
P21
P31
P496
0000-0002-6332-7436